DJIA 16,987.51 -61.49 -0.36%
NASDAQ 4,567.60 -24.21 -0.53%
S&P 500 1,985.54 -11.91 -0.60%
market minute promo

InterMune (NASDAQ: ITMN)

73.78 0.08 (0.11%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ITMN $73.78 0.11%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.66
Previous Close $73.70
Daily Range $73.63 - $73.79
52-Week Range $10.95 - $73.79
Market Cap $8.0B
P/E Ratio -28.35
Dividend (Yield) $0.00 (0.0%)
Volume 2,734,739
Average Daily Volume 5,658,958
Current FY EPS -$2.72





InterMune (ITMN) Description

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website:

News & Commentary

Up 35% on Buyout: InterMune inc Investor Key Takeaways

FDA's rejection of InterMune's Esbriet hurt investors, but Roche clearly thinks the drug will be approved.

10 Nasdaq stocks with returns of at least 240% in 2014

Is Roche At Risk Of Losing Its Way?

Roche's Cobas 6800/8800 Testing Systems Launched - Analyst Blog

Roche's Cobas 6800/8800 Testing Systems Launched - Analyst Blog

Buying Biotech

Notable ETF Outflow Detected - IWO, ITMN, PBYI, WEX

Merger Arbitrage Mondays - September 1, 2014

Will This Retail Stock Survive? (Podcast)

What You Need to Know About the Roche-InterMune Deal

Markets Reverse Early Morning Losses; Still Lower On The Day

Benzinga's Top Initiations

See More ITMN News...

ITMN's Top Competitors

ITMN $73.78 (0.11%)
Current stock: ITMN
AMGN $137.89 (-0.77%)
Current stock: AMGN
GILD $103.66 (-2.57%)
Current stock: GILD
BIIB $323.39 (-1.14%)
Current stock: BIIB